Sound waves to the calf could help you walk farther without pain
NCT ID NCT02652078
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether applying shockwave therapy to the calf muscles can improve blood flow and reduce pain in people with peripheral artery disease. About 138 adults with stable leg pain when walking will receive the treatment. The goal is to see if it helps them walk longer distances and feel better day-to-day.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Extracorporeal shockwave therapy (device)
- What this could lead to
- If it works, this could offer a non-invasive way to improve walking ability and quality of life for people with leg pain from peripheral artery disease.
- What could go wrong
- This is a relatively small, early-stage study without a placebo group, so results may not be conclusive. The therapy might not produce meaningful improvement in symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Academic Vascular Surgery Unit
Hull, Yorkshire, HU3 2JZ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Beetroot juice may boost heart blood flow and walking in leg artery disease
- Can a Pre-Surgery skin coating stop wound infections?
- Can a 'Scoring' balloon unclog leg arteries better and reduce stents?
- Can a temporary stent keep leg arteries open?
- Can a Lab-Grown artery graft outlast current options?
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test